TSHA icon

Taysha Gene Therapies
TSHA

Overview Fund Activity

48 hedge funds and large institutions have $362M invested in Taysha Gene Therapies in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 21 increasing their positions, 11 reducing their positions, and 5 closing their positions.

Holders
48
Holders Change
–
Holders Change %
0%
% of All Funds
0.84%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
5
Increased
21
Reduced
11
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
NCM
1
Nantahala Capital Management
Connecticut
$23.3M
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$7.83M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$15M
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$6.76M
5
Morgan Stanley
5
Morgan Stanley
New York
$2.33M

Top Sellers

1
Sands Capital Management
1
Sands Capital Management
Virginia
$0
2
OCA
2
Octagon Capital Advisors
New York
$0
3
UOTTAIMCU
3
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
$21.4M
4
PVI
4
Pura Vida Investments
New York
$0
5
Millennium Management
5
Millennium Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
PVI
51
Pura Vida Investments
New York
– -$717K -33,822 Closed
Millennium Management
52
Millennium Management
New York
– -$639K -30,165 Closed
D.E. Shaw & Co
53
D.E. Shaw & Co
New York
– -$243K -11,448 Closed
1 2
3